Advertisement

Topics

Miller Tabak Fund Manager Says Investors Are Ignoring the Upsides in Healthcare

09:50 EDT 20 May 2011 |

In October, New York-based investment firm Miller Tabak launched the Health Care Transformation Fund (MTHFX), which invests in managed care, biotech, pharmaceuticals, and medtech companies. Its top holdings include New York area pharma giants Bristol-Myers Squibb (NYSE: BMY) and Merck (NYSE: MRK), as well as Boston-based biotech Momenta Pharmaceuticals (NASDAQ: MNTA). The fund’s manager, Les Funtleyder, [...]

Original Article: Miller Tabak Fund Manager Says Investors Are Ignoring the Upsides in Healthcare

NEXT ARTICLE

More From BioPortfolio on "Miller Tabak Fund Manager Says Investors Are Ignoring the Upsides in Healthcare"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...